GlassScriptPhysician profile
Zeeshan Danawala
NPI 1609192558
$4,322.93
in general payments reported to CMS, 2019-2025
49 companies · $542 in 2025
The $542 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $215 · 2021: $591 · 2022: $1,117 · 2023: $663 · 2024: $533 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $475.26 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Abbvie INC. | $434.68 | 2019-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $367.59 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Teleflex LLC | $317.36 | 2022-2024 | Urolift |
| Agiliti Surgical, INC. | $258.32 | 2019-2024 | Sonablate Hifu, Sonablate |
| Pfizer INC. | $202.19 | 2019-2025 | |
| Verity Pharmaceuticals INC. | $149.76 | 2023-2025 | Trelstar |
| Neotract INC. | $139.08 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $132.10 | 2021 | |
| Sumitomo Pharma America, INC. | $131.25 | 2023-2025 | Orgovyx, Gemtesa |
| Biotissue Holdings INC. | $108.93 | 2021-2023 | |
| C. R. Bard, INC. & Subsidiaries | $92.58 | 2023 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $92.45 | 2019-2024 | Xyosted |
| Dendreon Pharmaceuticals LLC | $80.77 | 2019-2025 | Provenge |
| Allergan, INC. | $74.31 | 2019-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zeeshan Danawala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.